A5336 A Phase IIa, Double-blind, Placebo-controlled, Randomized Trial of Ruxolitinib in Antiretroviral-treated HIV-Infected Adults CAB Draft Discussion Tuesday, January 14, 2014 CWRU/UH CRS CAB Meeting
{}